Literature DB >> 25132422

An analysis of genetic factors related to risk of inflammatory bowel disease and colon cancer.

Bríd M Ryan1, Roger K Wolff2, Nicola Valeri3, Mohammed Khan1, Dillon Robinson1, Alessio Paone4, Elise D Bowman1, Abbie Lundgreen2, Bette Caan5, John Potter6, Derek Brown1, Carlo Croce4, Martha L Slattery2, Curtis C Harris7.   

Abstract

BACKGROUND AND AIMS: Patients with inflammatory bowel disease (IBD) have a higher risk of developing colorectal cancer than the general population. Genome-wide association studies have identified and replicated several loci associated with risk of IBD; however, it is currently unknown whether these loci are also associated with colon cancer risk.
METHODS: We selected 15 validated SNPs associated with risk of either Crohn's disease, ulcerative colitis, or both in previous GWAS and tested whether these loci were also associated with colon cancer risk in a two-stage study design.
RESULTS: We found that rs744166 in STAT3 was associated with colon cancer risk in two studies; however, the direction of the observation was reversed in TP53 mutant tumors possibly due to a nullification of the effect by mutant p53. The SNP, which lies within intron 1 of the STAT3 gene, was associated with lower expression of STAT3 mRNA in TP53 wild-type, but not mutant, tumors.
CONCLUSIONS: These data suggest that the STAT3 locus is associated with both IBD and cancer. Further understanding the function of this variant in relation to TP53 could possibly explain the role of this gene in autoimmunity and cancer. Furthermore, an analysis of this locus, specifically in a population with IBD, could help to resolve the relationship between this SNP and cancer. Published by Elsevier Ltd.

Entities:  

Keywords:  Colon cancer; Inflammatory bowel disease; STAT3

Mesh:

Substances:

Year:  2014        PMID: 25132422      PMCID: PMC8336584          DOI: 10.1016/j.canep.2014.07.003

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  65 in total

1.  Modulation of signal transducer and activator of transcription 3 activities by p53 tumor suppressor in breast cancer cells.

Authors:  Jiayuh Lin; Xiaohong Jin; Kori Rothman; Huey-Jen Lin; Huaijing Tang; William Burke
Journal:  Cancer Res       Date:  2002-01-15       Impact factor: 12.701

2.  Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis.

Authors:  Andre Franke; Tobias Balschun; Tom H Karlsen; Jürgen Hedderich; Sandra May; Tim Lu; Dörthe Schuldt; Susanna Nikolaus; Philip Rosenstiel; Michael Krawczak; Stefan Schreiber
Journal:  Nat Genet       Date:  2008-04-27       Impact factor: 38.330

3.  Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene.

Authors:  Eveliina Jakkula; Virpi Leppä; Anna-Maija Sulonen; Teppo Varilo; Suvi Kallio; Anu Kemppinen; Shaun Purcell; Keijo Koivisto; Pentti Tienari; Marja-Liisa Sumelahti; Irina Elovaara; Tuula Pirttilä; Mauri Reunanen; Arpo Aromaa; Annette Bang Oturai; Helle Bach Søndergaard; Hanne F Harbo; Inger-Lise Mero; Stacey B Gabriel; Daniel B Mirel; Stephen L Hauser; Ludwig Kappos; Chris Polman; Philip L De Jager; David A Hafler; Mark J Daly; Aarno Palotie; Janna Saarela; Leena Peltonen
Journal:  Am J Hum Genet       Date:  2010-02-12       Impact factor: 11.025

4.  Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.

Authors:  Nikolaos A Patsopoulos; Federica Esposito; Joachim Reischl; Stephan Lehr; David Bauer; Jürgen Heubach; Rupert Sandbrink; Christoph Pohl; Gilles Edan; Ludwig Kappos; David Miller; Javier Montalbán; Chris H Polman; Mark S Freedman; Hans-Peter Hartung; Barry G W Arnason; Giancarlo Comi; Stuart Cook; Massimo Filippi; Douglas S Goodin; Douglas Jeffery; Paul O'Connor; George C Ebers; Dawn Langdon; Anthony T Reder; Anthony Traboulsee; Frauke Zipp; Sebastian Schimrigk; Jan Hillert; Melanie Bahlo; David R Booth; Simon Broadley; Matthew A Brown; Brian L Browning; Sharon R Browning; Helmut Butzkueven; William M Carroll; Caron Chapman; Simon J Foote; Lyn Griffiths; Allan G Kermode; Trevor J Kilpatrick; Jeanette Lechner-Scott; Mark Marriott; Deborah Mason; Pablo Moscato; Robert N Heard; Michael P Pender; Victoria M Perreau; Devindri Perera; Justin P Rubio; Rodney J Scott; Mark Slee; Jim Stankovich; Graeme J Stewart; Bruce V Taylor; Niall Tubridy; Ernest Willoughby; James Wiley; Paul Matthews; Filippo M Boneschi; Alastair Compston; Jonathan Haines; Stephen L Hauser; Jacob McCauley; Adrian Ivinson; Jorge R Oksenberg; Margaret Pericak-Vance; Stephen J Sawcer; Philip L De Jager; David A Hafler; Paul I W de Bakker
Journal:  Ann Neurol       Date:  2011-12       Impact factor: 10.422

5.  Crohn's disease-associated carcinoma. A poorly recognized complication of inflammatory bowel disease.

Authors:  M E Richards; R R Rickert; F C Nance
Journal:  Ann Surg       Date:  1989-06       Impact factor: 12.969

Review 6.  Promises, delivery, and challenges of inflammatory bowel disease risk gene discovery.

Authors:  Steven R Brant
Journal:  Clin Gastroenterol Hepatol       Date:  2012-11-03       Impact factor: 11.382

7.  Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis.

Authors:  Mélissa Beaudoin; Philippe Goyette; Gabrielle Boucher; Ken Sin Lo; Manuel A Rivas; Christine Stevens; Azadeh Alikashani; Martin Ladouceur; David Ellinghaus; Leif Törkvist; Gautam Goel; Caroline Lagacé; Vito Annese; Alain Bitton; Jakob Begun; Steve R Brant; Francesca Bresso; Judy H Cho; Richard H Duerr; Jonas Halfvarson; Dermot P B McGovern; Graham Radford-Smith; Stefan Schreiber; Philip L Schumm; Yashoda Sharma; Mark S Silverberg; Rinse K Weersma; Mauro D'Amato; Severine Vermeire; Andre Franke; Guillaume Lettre; Ramnik J Xavier; Mark J Daly; John D Rioux
Journal:  PLoS Genet       Date:  2013-09-12       Impact factor: 5.917

8.  Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region.

Authors:  Jeffrey C Barrett; James C Lee; Charles W Lees; Natalie J Prescott; Carl A Anderson; Anne Phillips; Emma Wesley; Kirstie Parnell; Hu Zhang; Hazel Drummond; Elaine R Nimmo; Dunecan Massey; Kasia Blaszczyk; Timothy Elliott; Lynn Cotterill; Helen Dallal; Alan J Lobo; Craig Mowat; Jeremy D Sanderson; Derek P Jewell; William G Newman; Cathryn Edwards; Tariq Ahmad; John C Mansfield; Jack Satsangi; Miles Parkes; Christopher G Mathew; Peter Donnelly; Leena Peltonen; Jenefer M Blackwell; Elvira Bramon; Matthew A Brown; Juan P Casas; Aiden Corvin; Nicholas Craddock; Panos Deloukas; Audrey Duncanson; Janusz Jankowski; Hugh S Markus; Christopher G Mathew; Mark I McCarthy; Colin N A Palmer; Robert Plomin; Anna Rautanen; Stephen J Sawcer; Nilesh Samani; Richard C Trembath; Anath C Viswanathan; Nicholas Wood; Chris C A Spencer; Jeffrey C Barrett; Céline Bellenguez; Daniel Davison; Colin Freeman; Amy Strange; Peter Donnelly; Cordelia Langford; Sarah E Hunt; Sarah Edkins; Rhian Gwilliam; Hannah Blackburn; Suzannah J Bumpstead; Serge Dronov; Matthew Gillman; Emma Gray; Naomi Hammond; Alagurevathi Jayakumar; Owen T McCann; Jennifer Liddle; Marc L Perez; Simon C Potter; Radhi Ravindrarajah; Michelle Ricketts; Matthew Waller; Paul Weston; Sara Widaa; Pamela Whittaker; Panos Deloukas; Leena Peltonen; Christopher G Mathew; Jenefer M Blackwell; Matthew A Brown; Aiden Corvin; Mark I McCarthy; Chris C A Spencer; Antony P Attwood; Jonathan Stephens; Jennifer Sambrook; Willem H Ouwehand; Wendy L McArdle; Susan M Ring; David P Strachan
Journal:  Nat Genet       Date:  2009-11-15       Impact factor: 38.330

9.  Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility.

Authors:  Miles Parkes; Jeffrey C Barrett; Natalie J Prescott; Mark Tremelling; Carl A Anderson; Sheila A Fisher; Roland G Roberts; Elaine R Nimmo; Fraser R Cummings; Dianne Soars; Hazel Drummond; Charlie W Lees; Saud A Khawaja; Richard Bagnall; Denis A Burke; Catherine E Todhunter; Tariq Ahmad; Clive M Onnie; Wendy McArdle; David Strachan; Graeme Bethel; Claire Bryan; Cathryn M Lewis; Panos Deloukas; Alastair Forbes; Jeremy Sanderson; Derek P Jewell; Jack Satsangi; John C Mansfield; Lon Cardon; Christopher G Mathew
Journal:  Nat Genet       Date:  2007-06-06       Impact factor: 38.330

10.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.

Authors: 
Journal:  Nature       Date:  2007-06-07       Impact factor: 49.962

View more
  16 in total

1.  Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine.

Authors:  Shuji Ogino; Reiko Nishihara; Tyler J VanderWeele; Molin Wang; Akihiro Nishi; Paul Lochhead; Zhi Rong Qian; Xuehong Zhang; Kana Wu; Hongmei Nan; Kazuki Yoshida; Danny A Milner; Andrew T Chan; Alison E Field; Carlos A Camargo; Michelle A Williams; Edward L Giovannucci
Journal:  Epidemiology       Date:  2016-07       Impact factor: 4.822

2.  Proceedings of the second international molecular pathological epidemiology (MPE) meeting.

Authors:  Shuji Ogino; Peter T Campbell; Reiko Nishihara; Amanda I Phipps; Andrew H Beck; Mark E Sherman; Andrew T Chan; Melissa A Troester; Adam J Bass; Kathryn C Fitzgerald; Rafael A Irizarry; Karl T Kelsey; Hongmei Nan; Ulrike Peters; Elizabeth M Poole; Zhi Rong Qian; Rulla M Tamimi; Eric J Tchetgen Tchetgen; Shelley S Tworoger; Xuehong Zhang; Edward L Giovannucci; Piet A van den Brandt; Bernard A Rosner; Molin Wang; Nilanjan Chatterjee; Colin B Begg
Journal:  Cancer Causes Control       Date:  2015-05-09       Impact factor: 2.506

Review 3.  Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management.

Authors:  Shailja C Shah; Steven H Itzkowitz
Journal:  Gastroenterology       Date:  2021-10-29       Impact factor: 22.682

4.  Mapping hyper-susceptibility to colitis-associated colorectal cancer in FVB/NJ mice.

Authors:  Lauren Van Der Kraak; David Langlais; Serge Jothy; Nicole Beauchemin; Philippe Gros
Journal:  Mamm Genome       Date:  2016-03-15       Impact factor: 2.957

5.  Interaction between STAT3 gene polymorphisms and smoking on Crohn's disease susceptibility: a case-control study in a Chinese Han population.

Authors:  Jun-Hong Li; Ning Wu; Hong-Mei Yang; Hong-Bing Tang; Dong-Ping Bao; Jun-Min Ji
Journal:  Inflamm Res       Date:  2016-03-29       Impact factor: 4.575

Review 6.  Integration of molecular pathology, epidemiology and social science for global precision medicine.

Authors:  Akihiro Nishi; Danny A Milner; Edward L Giovannucci; Reiko Nishihara; Andy S Tan; Ichiro Kawachi; Shuji Ogino
Journal:  Expert Rev Mol Diagn       Date:  2015-12-04       Impact factor: 5.225

Review 7.  Quantifying the utility of single nucleotide polymorphisms to guide colorectal cancer screening.

Authors:  Mark A Jenkins; Enes Makalic; James G Dowty; Daniel F Schmidt; Gillian S Dite; Robert J MacInnis; Driss Ait Ouakrim; Mark Clendenning; Louisa B Flander; Oliver K Stanesby; John L Hopper; Aung K Win; Daniel D Buchanan
Journal:  Future Oncol       Date:  2016-02-01       Impact factor: 3.404

Review 8.  Colitis-associated colon cancer: Is it in your genes?

Authors:  Lauren Van Der Kraak; Philippe Gros; Nicole Beauchemin
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

9.  Ability of known susceptibility SNPs to predict colorectal cancer risk for persons with and without a family history.

Authors:  Mark A Jenkins; Aung K Win; James G Dowty; Robert J MacInnis; Enes Makalic; Daniel F Schmidt; Gillian S Dite; Mirosl Kapuscinski; Mark Clendenning; Christophe Rosty; Ingrid M Winship; Jon D Emery; Sibel Saya; Finlay A Macrae; Dennis J Ahnen; David Duggan; Jane C Figueiredo; Noralane M Lindor; Robert W Haile; John D Potter; Michelle Cotterchio; Steven Gallinger; Polly A Newcomb; Daniel D Buchanan; Graham Casey; John L Hopper
Journal:  Fam Cancer       Date:  2019-10       Impact factor: 2.375

10.  STAT3 polymorphism and Helicobacter pylori CagA strains with higher number of EPIYA-C segments independently increase the risk of gastric cancer.

Authors:  Gifone A Rocha; Andreia M C Rocha; Adriana D Gomes; César Ll Faria; Fabrício F Melo; Sérgio A Batista; Viviane C Fernandes; Nathálie B F Almeida; Kádima N Teixeira; Kátia S Brito; Dulciene Maria Magalhães Queiroz
Journal:  BMC Cancer       Date:  2015-07-19       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.